93 related articles for article (PubMed ID: 14663868)
1. Antimyelin antibodies in multiple sclerosis.
Mantegazza R
N Engl J Med; 2003 Dec; 349(23):2269-71; author reply 2269-71. PubMed ID: 14663868
[No Abstract] [Full Text] [Related]
2. Antimyelin antibodies with no progression to multiple sclerosis.
Pelayo R; Tintoré M; Montalban X; Rovira A; Espejo C; Reindl M; Berger T
N Engl J Med; 2007 Jan; 356(4):426-8. PubMed ID: 17251547
[No Abstract] [Full Text] [Related]
3. Antimyelin antibodies in multiple sclerosis.
Chaudhuri A; Behan PO
N Engl J Med; 2003 Dec; 349(23):2269-71; author reply 2269-71. PubMed ID: 14663869
[No Abstract] [Full Text] [Related]
4. Lack of association between antimyelin antibodies and progression to multiple sclerosis.
Berger T; Reindl M
N Engl J Med; 2007 May; 356(18):1888-9; author reply 1888-9. PubMed ID: 17476020
[No Abstract] [Full Text] [Related]
5. Antimyelin antibodies in multiple sclerosis.
Maguire GA
N Engl J Med; 2003 Dec; 349(23):2269-71; author reply 2269-71. PubMed ID: 14657439
[No Abstract] [Full Text] [Related]
6. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event.
Berger T; Rubner P; Schautzer F; Egg R; Ulmer H; Mayringer I; Dilitz E; Deisenhammer F; Reindl M
N Engl J Med; 2003 Jul; 349(2):139-45. PubMed ID: 12853586
[TBL] [Abstract][Full Text] [Related]
7. Do myelin-directed antibodies predict multiple sclerosis?
Antel JP; Bar-Or A
N Engl J Med; 2003 Jul; 349(2):107-9. PubMed ID: 12853581
[No Abstract] [Full Text] [Related]
8. [Anti-MOG immunoglobulin IgM].
Fukaura H; Kikuchi S
Nihon Rinsho; 2005 Jul; 63 Suppl 7():593-5. PubMed ID: 16111341
[No Abstract] [Full Text] [Related]
9. [Myelin oligodendrocyte glycoprotein (MOG) antibody and demyelination].
Fukaura H
Nihon Rinsho; 2010 Jun; 68 Suppl 6():637-40. PubMed ID: 20942151
[No Abstract] [Full Text] [Related]
10. Antibodies to myelin oligodendrocyte glycoprotein as a biomarker in multiple sclerosis--are we there yet?
Amor S; Giovannoni G
Mult Scler; 2007 Nov; 13(9):1083-5. PubMed ID: 17967836
[No Abstract] [Full Text] [Related]
11. Myelin oligodendrocyte glycoprotein antibodies and multiple sclerosis in healthy young adults.
Wang H; Munger KL; Reindl M; O'Reilly EJ; Levin LI; Berger T; Ascherio A
Neurology; 2008 Oct; 71(15):1142-6. PubMed ID: 18753473
[TBL] [Abstract][Full Text] [Related]
12. [Multiple sclerosis. Biomarkers for deciding treatment].
Meinl E; Voltz R
MMW Fortschr Med; 2004 May; 146 Spec No 2():57-8. PubMed ID: 15376703
[No Abstract] [Full Text] [Related]
13. [Immunologic tests: Myelin basic protein and anti-myelin basic protein antibody].
Ohta M; Ohta K
Nihon Rinsho; 2005 Jul; 63 Suppl 7():596-8. PubMed ID: 16111342
[No Abstract] [Full Text] [Related]
14. Antimyelin basic protein and antimyelin antibody-producing cells in multiple sclerosis.
Olsson T; Baig S; Höjeberg B; Link H
Ann Neurol; 1990 Feb; 27(2):132-6. PubMed ID: 1690527
[TBL] [Abstract][Full Text] [Related]
15. Lack of association between antimyelin antibodies and progression to multiple sclerosis.
Kuhle J; Pohl C; Mehling M; Edan G; Freedman MS; Hartung HP; Polman CH; Miller DH; Montalban X; Barkhof F; Bauer L; Dahms S; Lindberg R; Kappos L; Sandbrink R
N Engl J Med; 2007 Jan; 356(4):371-8. PubMed ID: 17251533
[TBL] [Abstract][Full Text] [Related]
16. [Myelin basic protein, anti-sulfated glucuronyl paragloboside (SGPG) antibody and anti-P0 antibody].
Ohta M; Ohta K
Nihon Rinsho; 2010 Jun; 68 Suppl 6():641-4. PubMed ID: 20942152
[No Abstract] [Full Text] [Related]
17. Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS.
Tomassini V; De Giglio L; Reindl M; Russo P; Pestalozza I; Pantano P; Berger T; Pozzilli C
Mult Scler; 2007 Nov; 13(9):1086-94. PubMed ID: 17468447
[TBL] [Abstract][Full Text] [Related]
18. Serum antibodies to conformational and linear epitopes of myelin oligodendrocyte glycoprotein are not elevated in the preclinical phase of multiple sclerosis.
Chan A; Decard BF; Franke C; Grummel V; Zhou D; Schottstedt V; Toyka KV; Hemmer B; Gold R
Mult Scler; 2010 Oct; 16(10):1189-92. PubMed ID: 20685767
[TBL] [Abstract][Full Text] [Related]
19. Detection of myelin autoantibodies: evaluation of an assay system for diagnosis of multiple sclerosis in differentiation from other central nervous system diseases.
Langkamp M; Hörnig SC; Hörnig JB; Kirschner M; Pridzun L; Kornhuber ME
Clin Chem Lab Med; 2009; 47(11):1395-400. PubMed ID: 19912047
[TBL] [Abstract][Full Text] [Related]
20. Catalytic autoantibodies in multiple sclerosis: pathogenetic and clinical aspects.
Misikov VK; Kimova MV; Durova OM; Gabibov AG; Suchkov SV; Vorobev II; Ponomarenko NA
Bull Exp Biol Med; 2005 Jan; 139(1):85-8. PubMed ID: 16142285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
